Navigation Links
Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
Date:12/18/2007

President of U.S. Medical Affairs at Actelion. "Sure Steps is a unique program that provides meaningful assistance to these patients and resources to learn more about their condition beginning immediately after they start their treatment."

About PAH Pathways and Sure Steps

PAH Pathways(TM) is Actelion's service and support program for physicians and their patients currently on either of Actelion's PAH medications, including Tracleer and Ventavis. The program is designed to provide access to therapy, ensuring patients receive therapy as quickly as possible, and comprehensive financial and reimbursement support to eligible patients. In addition, PAH Pathways recently introduced a program that offers eligible patients starting on Tracleer with their first month of therapy at no cost to the patient.

Sure Steps, an important part of the PAH Pathways offering, is a support and education program for patients with PAH who are taking one of Actelion's PAH medications. The program provides ongoing information and personal assistance to help these patients manage their condition. Patients enrolled in Sure Steps receive direct access to a nurse counselor who can help answer questions regarding PAH or Tracleer, ongoing informational newsletters, and important tools to help them cope with PAH. Over 3,500 patients have enrolled in Sure Steps to date. Eligible patients can enroll by calling 1-866-682-7873. Sure Steps is also available to patients who are taking Ventavis for the treatment PAH.

About Tracleer(R) in Pulmonary Arterial Hypertension (PAH)

Tracleer(R) (bosentan), the first oral dual endothelin receptor antagonist, is approved for the treatment of pulmonary arterial hypertension (PAH) World Health Organization (WHO) Functional Class III or IV and made available by Actelion Ltd. subsidiaries in the United States, the European Union, Japan, Australia, Canada, Switzerland and other markets worldwide.

Tracleer requires attention to t
'/>"/>

SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. International Survey Shows People Over Forty Ignore Risk of Blindness
3. 2007 Global Survey Identifies Characteristics of Supply Chain Leaders
4. Survey Sees Mass. CEOs as Bullish on Own Businesses
5. Boehringer Ingelheim Receives Top Honor as Worlds Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey
6. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
7. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that the ... and Mexico currently faces ... approved agents, the anticipated label extension of Boehringer ... of emerging biologics will substantially increase the competitiveness ... IL-5 inhibitors will introduce a new dynamic to the ...
(Date:8/21/2014)... HONG KONG , Aug. 21, 2014  China Cord ... today announced its plan to release financial results for ... August 28, 2014, after market close in the US.  ... call at 8:00 a.m. ET on Friday, August 29, ... brief overview of the Company,s recent developments, followed by ...
(Date:8/21/2014)... 21, 2014 Ontotext S4 , ... Ontotext . Now the same enterprise hardened ... structured and unstructured data is available to start-ups and ... enterprise technology. Organizations that do not have resources to ... can use S4 since there is no need for ...
(Date:8/21/2014)... of last week RENU 28, the world's first and only ... purchase in Australia and New Zealand, and the response has ... if you think about the definition of aging, it's really ... your body. If you think about the definition of anti-aging, ... RENU 28 does is it works with these tiny little ...
Breaking Biology Technology:Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4RENU 28 Skin Care Now Available in Australia and New Zealand 2
... a pair of information-carrying molecules: DNA and RNA. These ... they display hereditymeaning they can encode and pass on ... processes of Darwinian evolution. A long-debated question ... molecules other than DNA and RNA. John ...
... new applications based on nanoimprinting techniques (NIL) is evolving at ... be overcome in order to reach the market? How do ... from the industry? What are the tools needed for each ... this topic, i.e. Nanopatterning, Production and Applications based on Nanoimprinting ...
... April 19, 2012 RayBiotech, Inc. today announced that ... diagnostic core facilities at academic and government research institutes ... of the partnership program, core diagnostics facilities will be ... a component of their current services offerings at no ...
Cached Biology Technology:Strange cousins: Molecular alternatives to DNA, RNA offer new insight into life's origins 2Strange cousins: Molecular alternatives to DNA, RNA offer new insight into life's origins 3Strange cousins: Molecular alternatives to DNA, RNA offer new insight into life's origins 4Low-cost optical components through nanoimprinting lithography 2Low-cost optical components through nanoimprinting lithography 3RayBiotech, Inc. Announces New Diagnostic Core Facility Partnering Program 2
(Date:8/22/2014)... a leading source of information for businesses and professionals, ... Riverside in its 2014 list of "some of the ... generate the list, the company analyzed citation data over ... has had enormous impact. , The following UC Riverside ... the greatest number of highly cited papers in one ...
(Date:8/22/2014)... August 21, 2014 Diabetes affects nearly 10 ... complaints of diabetics: constant finger pricking to test ... Chemical Biology reports the development of a protein ... accurate results for diabetes patients. In the American ... Daunert, Ph.D., shows off her "designer protein" that ...
(Date:8/22/2014)... (Edmonton) Thanks to important discoveries in basic and ... cancer has mobilized into a complex offensive spanning ... of Alberta chemistry lab could help find new ... developed a compound that targets a specific enzyme ... activity in cells from brain tumours. , Chemistry ...
Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2New enzyme targets for selective cancer therapies 2New enzyme targets for selective cancer therapies 3
... Results from two French studies presented today at the ... clinical practice in the treatment of patients with severe ... demonstrated the positive potential of performing liver transplantation for ... the recommended 6-months rule (required minimum of recorded abstinence ...
... Results from two studies presented today at the International ... devices may not confer a survival advantage for severe ... among a small sub-group of patients show promise. ... is valued as a detoxification treatment option for patients ...
... for Chemoreception Sciences (AChemS), a US-based scientific organization, is ... gathering to present new information on the role of ... in humans as well as animals. Smell and taste ... senses serve as important warning systems, alerting us to ...
Cached Biology News:New insights into treatment options for patients suffering from severe alcoholic hepatitis 2New findings on taste and smell 2New findings on taste and smell 3
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
TXNL2 Antibody...
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...
Biology Products: